Company intelligence / Profile preview

Wuzhou Zhongheng

Wuzhou, Guangxi, China

Ownership: Private
Development stage: Other

Overview

Wuzhou Zhongheng is a leading Chinese pharmaceutical manufacturer with commercial-stage products covering small molecules, biologics, and traditional Chinese medicine, including antineoplastic drugs, digestive drugs, anti-infectives, parenteral nutrition, gout and cough remedies, as well as TCM-based consumer health and oral care products. Their subsidiary Guangxi Wuzhou Pharmaceutical is a major chain enterprise, and the group is recognized among top Chinese pharma and TCM companies.

Therapeutic areas: RheumatologyMetabolic DisordersInfectious DiseasesGastroenterologyPulmonologyOtherOncology
Modalities: Small moleculeBiologicTraditional Chinese medicine (TCM)
Industry: Pharma

Drug pipeline

1 asset

Shuang Hua Bai He Pian

Unknown

Beyond the preview

Go deeper on Wuzhou Zhongheng.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuzhou Zhongheng.

Explore the full profile